Related Experiment Videos
Ovariectomy and subchronic estradiol-17 beta administration decrease dopamine D1 and D2 receptors in rat striatum
J A Tonnaer1, T Leinders, A M van Delft
1CNS Pharmacology Department, Organon International BV, Oss, The Netherlands.
Abstract:
Ovariectomy and subchronic estradiol-17 beta cause a down-regulation of dopamine D1 and, to a lesser extent, D2 receptors in rat striatum. An intracellular mechanism mediates the DA receptor down-regulation, as various estrogens do not interact with membrane-bound DA receptors in vitro. A common denominator, e.g. enhanced DA turnover, is suggested to mediate the estradiol-induced DA receptor down-regulation. Ovarian factors other than estradiol are additionally proposed to be involved in the regulation of striatal DA receptors.
Insights
Ovariectomy and estradiol down-regulate dopamine receptors in rat brains, suggesting an intracellular mechanism. Other ovarian factors may also influence these dopamine receptors.
Area of Science:
- Neuroendocrinology
- Molecular Pharmacology
Background:
- The striatum is a key brain region for motor control and reward, heavily influenced by dopamine.
- Hormonal fluctuations, particularly from the ovaries, are known to impact neurotransmitter systems.
Purpose of the Study:
- To investigate the effects of ovariectomy and estradiol administration on dopamine receptor expression in the rat striatum.
- To explore the potential mechanisms underlying estradiol-induced dopamine receptor regulation.
Main Methods:
- Ovariectomy was performed on rats.
- Subchronic administration of estradiol-17 beta was administered.
- Dopamine D1 and D2 receptor levels in the striatum were assessed.
- In vitro assays were used to examine estrogen-dopamine receptor interactions.
Main Results:
- Ovariectomy and estradiol treatment led to a significant down-regulation of dopamine D1 receptors.
- A less pronounced down-regulation of dopamine D2 receptors was observed.
- Evidence suggests an intracellular mechanism, as estrogens did not directly interact with membrane-bound receptors in vitro.
- Enhanced dopamine turnover is proposed as a mediator of estradiol's effect.
Conclusions:
- Estradiol plays a crucial role in down-regulating striatal dopamine receptors, likely via intracellular pathways.
- Dopamine turnover may be a key factor in this regulatory process.
- Ovarian factors beyond estradiol might also contribute to the modulation of striatal dopamine receptors.